|
23 Jan 2020 |
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
|
|
23 Jan 2020 |
Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
|
|
21 Jan 2020 |
Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease
|
|
12 Jan 2020 |
Positive Final 2-Year Topline Data in Completed DC Vaccine Phase I/II trial in AML Patients
|
|
09 Jan 2020 |
SELLAS Commences Pivotal Phase 3 REGAL Study of Galinpepimut-S (GPS) in Patients with Acute Myeloid Leukemia (AML)
|
|
09 Jan 2020 |
Phase I clinical trial results published for Invectys DNA Vaccine for Cancer using PharmaJet Needle-free injector
|
|
07 Jan 2020 |
Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers
|
|
30 Dec 2019 |
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers
|
|
27 Dec 2019 |
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
|
|
20 Dec 2019 |
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy
|
|
20 Dec 2019 |
First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
|
|
16 Dec 2019 |
Heat Biologics Announces First Patient Dosed in the First Phase 1 Trial of HS-130
|
|
15 Dec 2019 |
Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE
|
|
13 Dec 2019 |
Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
|
|
13 Dec 2019 |
Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer
|
|
11 Dec 2019 |
GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019
|
|
10 Dec 2019 |
Emergex Successfully Completes Preclinical Testing of its Lead ‘Set-Point’ Vaccine Candidate for Dengue Fever and Other Flaviviruses
|
|
09 Dec 2019 |
Nouscom - First Patient Dosed in a Phase 1 Trial With NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine, in MSI-High Solid Tumors
|
|
06 Dec 2019 |
Meissa Vaccines Receives FDA Clearance of IND Application for a Phase 1 Clinical Trial of MV-012-968 for Respiratory Syncytial Virus
|
|
05 Dec 2019 |
Osivax Enters Agreement with U.S. National Institutes of Health to Test Universal Flu Vaccine Candidate
|
|
04 Dec 2019 |
Advaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer
|
|
26 Nov 2019 |
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
|
|
26 Nov 2019 |
Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies
|
|
24 Nov 2019 |
Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting
|
|
23 Nov 2019 |
Emergent BioSolutions Presents Positive Immunogenicity Results From Phase 2 Study of Its Investigational Chikungunya VLP Vaccine Candidate
|
